Target
NLRP3
1 abstract
Abstract
KEVLAR: A phase 2b, multi-institutional, randomized, blinded, controlled trial to assess the safety and efficacy of two schedules of RRx-001 vs. standard of care in attenuating severe oral mucositis (SOM) in patients receiving concomitant chemoradiation (CRT) for the treatment of locally advanced squamous cell carcinomas (SCC) of the oral cavity (OC) or oropharynx (OPC).Org: EpicentRx, La Jolla, CA, Torrey Pines, CA, Clinical Trials Innovations, Mountain View, CA,